Heterogeneity of COVID-19 outbreak in Italy

Heterogeneity of COVID-19 outbreak in Italy


  • Bruno Alessandro Rivieccio AREU - Regional Emergency Service Agency, Milano, Italy
  • Ester Luconi Fondazione IRCCS Ca’ Granda Ospedale Maggiore di Milano, Italy
  • Patrizia Boracchi Department of Clinical Sciences and Community Health and DSRC, University of Milan, Italy
  • Elena Pariani Dept Biomedical Sciences for Health, University of Milan, Italy
  • Luisa Romanò Dept Biomedical Sciences for Health, University of Milan, Italy
  • Silvia Salini Department of Economics, Management and Quantitative Methods and DSRC, University of Milan, Italy
  • Silvana Castaldi Università degli Studi di Milano http://orcid.org/0000-0003-1716-6624
  • Elia Biganzoli Department of Clinical Sciences and Community Health and DSRC , University of Milan, Italy
  • Massimo Galli Department of Biomedical and Clinical Sciences "L. Sacco", University of Milan, Italy


COVID 19 - outbreak


An outbreak of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) started in December 2019 in China and was declared a pandemic on 11.03.2020 by WHO. Italy is one of the most afflicted Country by this epidemic with 136,110 confirmed cases and 16,654 deaths on 9.4.2020 (at the same date, the Ministry of Health was reporting 143,626 cases).  During these few months the National Health Service have made a great effort to cope with the increasing request of intensive care beds and all the elective activities in hospital have been suspended. Data from the different Italian regions shows different patterns of positive and dead for this syndrome. Moreover, striking differences of the observed lethality of the infections among different areas were immediately evident from the epidemic reports. It will be of critical relevance to understand the expected evolution of the first lock-down phase, driving the exhaustion of the Covid-19 outbreak.(www.actabiomedica.it)

Author Biography

Silvana Castaldi, Università degli Studi di Milano

professore associato Dipartimento di Scienze Biomediche per la Salute



Coronavirus disease 2019 (COVID-19) Situation Report – 51, 11 March 2020, https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200311-sitrep-51-covid-19.pdf?sfvrsn=1ba62e57_4

Riccardo F., Andrianou X., Bella A. et Al., Epidemia COVID-19. https://www.epicentro.iss.it/coronavirus/bollettino/Bollettino-sorveglianza-integrata-COVID-19_9-aprile-2020.pdf

Lai A, Bergna A, Acciarri C, Galli M, Zehender G. Early phylogenetic estimate of the effective reproduction number of SARS-CoV-2. J Med Virol 2020; : 14–8.

Decreto del Presidente del Consiglio dei Ministri 23 febbraio 2020https://www.gazzettaufficiale.it/eli/id/2020/02/23/20A01228/sg

Nacoti M, Ciocca A, Giupponi A, Brambillasca P. At the Epicenter of the Covid-19 Pandemic and Humanitarian Crises in Italy : Changing Perspectives on Preparation and Mitigation. 2020; : 1–5. NEJM Catalyst https://catalyst.nejm.org/doi/full/10.1056/CAT.20.0080







How to Cite

Rivieccio BA, Luconi E, Boracchi P, Pariani E, Romanò L, Salini S, et al. Heterogeneity of COVID-19 outbreak in Italy. Acta Biomed [Internet]. 2020 Apr. 20 [cited 2024 Jul. 25];91(2):31-4. Available from: https://www.mattioli1885journals.com/index.php/actabiomedica/article/view/9579